Morbid obesity’s impact on COVID-19 patients requiring venovenous extracorporeal membrane oxygenation

Written By CCRG

Javidfar, J., Zaaqoq, A. M., Labib, A., Barnett, A. G., Hayanga, J. A., Eschun, G., Yamashita, M. H., Jacobs, J. P., Heinsar, S., Suen, J. Y., Fraser, J. F., Bassi, G. L., Arora, R. C., Peek, G. J., & Covid-19 Critical Care Consortium (COVID Critical) Perfusion DOI: 10.1177/02676591231156487

Introduction: Obesity is associated with a worse prognosis in COVID-19 patients with acute respiratory distress syndrome (ARDS). Veno-venous (V-V) Extracorporeal Membrane Oxygenation (ECMO) can be a rescue option, however, the direct impact of morbid obesity in this select group of patients remains unclear.

CCRG
Previous

Hemorrhage, Disseminated Intravascular Coagulopathy, and Thrombosis Complications Among Critically Ill Patients with COVID-19
Next

Cerebrovascular Complications of COVID-19 on Venovenous Extracorporeal Membrane Oxygenation